PriceTargets.com logo

LHC Group - LHCG Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$169.81 As of 02/22/2023 09:00 PM ET
▲ +0.8 (0.47%)
Get New LHC Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for LHCG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for LHCG

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for LHC Group in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $169.81.

This chart shows the closing price for LHCG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in LHC Group. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/2/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/31/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/1/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/28/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/25/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/25/2022Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$190.00 ➝ $170.00Medium
4/12/2022BarclaysBoost TargetEqual Weight$154.00 ➝ $170.00Low
4/4/2022Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$172.00 ➝ $170.00Low
3/31/2022Truist FinancialDowngradeBuy ➝ HoldLow
3/30/2022StephensDowngradeOverweight ➝ Equal WeightLow
3/30/2022BenchmarkDowngradeBuy ➝ HoldMedium
3/30/2022Credit Suisse GroupDowngradeOutperform ➝ Neutral$181.00 ➝ $170.00Medium
3/29/2022William BlairDowngradeOutperform ➝ Market PerformLow
3/10/2022Truist FinancialBoost TargetBuy$175.00 ➝ $185.00High
2/28/2022Credit Suisse GroupLower TargetOutperform$184.00 ➝ $181.00Medium
2/24/2022BenchmarkLower TargetBuy$190.00 ➝ $170.00High
11/10/2021SVB LeerinkBoost TargetMarket Perform$149.00 ➝ $151.00Medium
11/5/2021BarclaysLower TargetEqual Weight$207.00 ➝ $171.00Low
11/5/2021Credit Suisse GroupLower TargetOutperform$191.00 ➝ $184.00High
11/5/2021Royal Bank of CanadaLower TargetOutperform$192.00 ➝ $180.00High
10/26/2021CowenDowngradeOutperform ➝ Market Perform$209.00 ➝ $150.00High
10/19/2021Royal Bank of CanadaLower TargetOutperform$253.00 ➝ $192.00High
10/19/2021SVB LeerinkLower TargetMarket Perform$173.00 ➝ $149.00High
10/19/2021Credit Suisse GroupLower TargetOutperform$252.00 ➝ $191.00High
10/19/2021Deutsche Bank AktiengesellschaftLower TargetBuy$245.00 ➝ $190.00High
10/18/2021BenchmarkLower TargetBuy$260.00 ➝ $210.00High
10/13/2021Truist FinancialLower TargetBuy$240.00 ➝ $185.00Low
9/27/2021SVB LeerinkInitiated CoverageMarket Perform$173.00Low
9/23/2021UBS GroupInitiated CoverageNeutral$170.00Low
9/22/2021Deutsche Bank AktiengesellschaftLower TargetBuy$260.00 ➝ $245.00Low
9/9/2021CowenInitiated CoverageOutperform$209.00Medium
8/19/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy$260.00Low
8/12/2021BarclaysDowngradeOverweight ➝ Equal Weight$245.00 ➝ $207.00Low
8/10/2021Credit Suisse GroupLower TargetOutperform$255.00 ➝ $252.00Medium
7/9/2021BenchmarkBoost TargetPositive ➝ Buy$250.00 ➝ $260.00Medium
2/8/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$240.00 ➝ $260.00Medium
1/25/2021Credit Suisse GroupInitiated CoverageOutperform$255.00Low
1/5/2021Truist FinancialBoost Target$245.00 ➝ $260.00N/A
11/17/2020OppenheimerReiterated RatingBuyLow
11/5/2020OppenheimerBoost TargetOutperform$245.00 ➝ $250.00High
10/19/2020OppenheimerBoost TargetOutperform$233.00 ➝ $245.00Medium
8/12/2020UBS GroupDowngradeBuy ➝ Neutral$170.00 ➝ $210.00Low
8/11/2020StephensBoost TargetOverweight$200.00 ➝ $225.00High
7/9/2020SunTrust BanksBoost TargetBuy$200.00 ➝ $220.00Low
7/1/2020BenchmarkBoost TargetBuy$160.00 ➝ $190.00Medium
6/3/2020Deutsche Bank AktiengesellschaftBoost TargetPositive ➝ Buy$160.00 ➝ $165.00High
5/21/2020SunTrust BanksBoost TargetBuy$160.00 ➝ $200.00Medium
5/14/2020UBS GroupLower TargetBuy$179.00 ➝ $170.00Low
3/20/2020BenchmarkBoost TargetBuy$144.00 ➝ $160.00High
3/4/2020Royal Bank of CanadaReiterated RatingBuy$180.00Medium
3/2/2020StephensLower TargetOverweight$161.00 ➝ $150.00Medium
2/28/2020Robert W. BairdLower TargetNeutral$170.00 ➝ $150.00High
12/6/2019SunTrust BanksBoost TargetBuy$145.00 ➝ $160.00Low
11/7/2019William BlairReiterated RatingOutperformLow
10/21/2019StephensInitiated CoverageOverweight$132.00Low
9/23/2019UBS GroupBoost TargetBuy$133.00 ➝ $136.00Low
9/16/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy$145.00Medium
8/9/2019Royal Bank of CanadaSet TargetBuy$135.00Medium
8/9/2019OppenheimerBoost TargetOutperform$125.00 ➝ $146.00Medium
8/9/2019BarclaysBoost TargetEqual Weight$113.00 ➝ $120.00Medium
5/13/2019Royal Bank of CanadaBoost TargetOutperform$130.00Low
5/12/2019BarclaysReiterated RatingNeutral ➝ HoldLow
5/10/2019UBS GroupSet TargetBuy$133.00Low
5/9/2019Jefferies Financial GroupBoost TargetBuy$125.00 ➝ $130.00High
(Data available from 4/25/2019 forward)

News Sentiment Rating

0.76 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/28/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/28/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/27/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/27/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/26/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/25/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/26/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/25/2024

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
LHC Group logo
LHC Group, Inc. provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations. The Home Health segment offers a wide range of services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education. The Hospice Services segment offer a wide range of services, including pain and symptom management, emotional and spiritual support, inpatient and respite care, homemaker services, and counseling. The Home & Community-Based Services segment are performed by paraprofessional personnel, and include assistance to the elderly, chronically ill, and disabled patients with activities of daily living. The Facility Based Services segment includes long-term acute care hospitals treats patients with severe medical conditions who require a high-level of care and frequent monitoring by physicians and other clinical perso
Read More

Today's Range

Now: $169.81
Low: $169.16
High: $169.83

50 Day Range

MA: $166.14
Low: $156.74
High: $169.81

52 Week Range

Now: $169.81
Low: $115.32
High: $169.84

Volume

1,283,600 shs

Average Volume

576,665 shs

Market Capitalization

$5.27 billion

P/E Ratio

82.83

Dividend Yield

N/A

Beta

0.43

Frequently Asked Questions

What sell-side analysts currently cover shares of LHC Group?

The following Wall Street sell-side analysts have issued research reports on LHC Group in the last year: StockNews.com.
View the latest analyst ratings for LHCG.

What is the current price target for LHC Group?

0 Wall Street analysts have set twelve-month price targets for LHC Group in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for LHC Group in the next year.
View the latest price targets for LHCG.

What is the current consensus analyst rating for LHC Group?

LHC Group currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for LHCG.

What other companies compete with LHC Group?

Other companies that are similar to LHC Group include Amedisys, AdaptHealth, Chemed, Option Care Health and BrightSpring Health Services. Learn More about companies similar to LHC Group.

How do I contact LHC Group's investor relations team?

LHC Group's physical mailing address is 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508. The health services provider's listed phone number is (337) 233-1307 and its investor relations email address is [email protected]. The official website for LHC Group is www.lhcgroup.com. Learn More about contacing LHC Group investor relations.